Article
Rhabdomyosarcoma fusion oncoprotein initially pioneers a neural signature in vivo
2024-07-16
Abstract excerpt
Fusion-positive rhabdomyosarcoma is an aggressive pediatric cancer molecularly characterized by arrested myogenesis. The defining genetic driver, PAX3::FOXO1, functions as a chimeric gain-of-function transcription factor. An incomplete understanding of PAX3::FOXO1’s in vivo epigenetic mechanisms has hindered therapeutic development. Here, we establish a PAX3::FOXO1 zebrafish injection model and semi-automated ChIP...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 526f7000-1d45-50ef-aaab-b29f5991417a
- DOI
- 10.1101/2024.07.12.603270
